Fiasp PumpCart (insulin aspart)
Fiasp PumpCart (insulin aspart)
Fiasp PumpCart (insulin aspart)
Name Review Group form - questions and answers
NovoRapid PumpCart (insulin aspart)
Allergen products development for immunotherapy and allergy diagnosis in moderate to low-sized study populations - Scientific guideline
Human medicines European public assessment report (EPAR): Invokana, canagliflozin, Date of authorisation: 15/11/2013, Revision: 27, Status: Authorised
EMA/PE/0000232894
Minutes - Executive Steering Group on Shortages and Safety of Medicinal Products (MSSG) - 20 November 2025
EMA Cancer Medicines Forum (CMF) meeting with industry stakeholders on cancer treatment optimisation, Online, European Medicines Agency, Amsterdam, the Netherlands, from 14 November 2025, 13:30 (CET) to 14 November 2025, 17:30 (CET)
List of European Union reference dates (EURD) and frequency of submission of periodic safety update reports (PSURs)
Call for user acceptance testers for the read functionality in the Public Product Management Service (PMS) Application Programming Interface (API)